Anticoagulant Protein S in COVID-19: The Low Activity Level Is Probably Secondary
Am J Ther
.
2021 Jan-Feb;28(1):e139-e140.
doi: 10.1097/MJT.0000000000001306.
Authors
Cristian Baicus
1
,
Laura Elena Stoichitoiu
,
Larisa Pinte
,
Camelia Badea
Affiliation
1
Department of Internal Medicine, Colentina University Hospital Bucharest, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
PMID:
33369912
DOI:
10.1097/MJT.0000000000001306
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / blood*
COVID-19 / complications
Humans
Inflammation / blood
Inflammation / etiology
Lung / pathology
Protein S / analysis*
Thrombosis / blood
Substances
PROS1 protein, human
Protein S